Atlas Trials

Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result

Clinical trial NCT01024959 · COMPLETED

Trial details

NCT number
NCT01024959
Sponsor
Gen-Probe, Incorporated
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2009-08-01
Primary completion
2010-04-01
Enrollment
507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.